Endemic infections in Southeast Asia provide new insights to the phenotypic spectrum of primary immunodeficiency disorders

Asian Pacific Journal of Allergy and Immunology

Volumn 31, Issue 3, 2013, Pages 217-226

  Lee, Pamela Pui Wah ^a   Lau, Yu Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Asian primary immunodeficiency network; Chromobacterium violaceum; Melioidosis; Mycobacteria; Penicilliosis; Pimary immunodeficiencies

Indexed keywords

BCG VACCINE;

AUTOINFLAMMATORY DISEASE; CHROMOBACTERIUM VIOLACEUM; COMPLEMENT DEFICIENCY; DISEASE TRANSMISSION; HUMAN; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; INNATE IMMUNITY; MELIOIDOSIS; MULTICENTER STUDY (TOPIC); MUTATION; PENICILLIUM MARNEFFEI; PHAGOCYTE DYSFUNCTION; PHENOTYPE; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; SOUTHEAST ASIA; TUBERCULOSIS; WISKOTT ALDRICH SYNDROME; X LINKED AGAMMAGLOBULINEMIA; BACTERIAL INFECTION; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; MALE; MYCOSIS;

ASIA, SOUTHEASTERN; BACTERIAL INFECTIONS; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; HUMANS; MALE; MYCOSES;

EID: 84887591016     PISSN: 0125877X     EISSN: 22288694     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2011;2:54.
2. Goh DYT, Shek LP, Lee BW. Acute respiratory tract infections in children: outpatient management [Internet]. National University Hospital, Bulletin 10, 1999 [cited 2013 Jul 27]. Available from: http://www.nuh.com.sg/wbn/slot/u1756/bulletins/bulletin_10.pdf.
3. Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A Phenotypic Approach for IUIS PID Classification and Diagnosis: Guidelines for Clinicians at the Bedside. J Clin Immunol. 2013;33:1078-1087.
4. de Vries E, Driessen G. Educational paper: Primary immunodeficiencies in children: a diagnostic challenge. Eur J Pediatr. 2011;170:169-177.
5. Burrows PD, Fischer A. Building networks for immunodeficiency diseases and immunology training. Nat Immunol. 2008;9:1005-1007.
6. Primary Immunodeficiency Care and Research Center, Chang Gung Memorial Hospital [Internet]. [cited 2013 Jul 27]. Available from: http://www1.cgmh.org.tw/chldhos/intr/c4a80/06index003_News.htm.
7. Lee PP, Lau YL. Primary immunodeficiencies: new disease in an old country. Cell Mol Immunol. 2009;6:397-406.
8. Lee PP, Lau YL. Improving care, education, and research: the Asian primary immunodeficiency network. Ann N Y Acad Sci. 2011;1238:33-41.
9. Lee PP, Chan KW, Jiang L, Chen T, Li C, Lee TL, et al. Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis. Pediatr Infect Dis J. 2008;27:224-230.
10. Lee PP, Chen TX, Jiang LP, Chen J, Chan KW, Lee TL, et al. Clinical and molecular characteristics of 35 Chinese children with Wiskott-Aldrich syndrome. J Clin Immunol. 2009;29:490-500.
11. Lee PP, Chen TX, Jiang LP, Chan KW, Yang W, Lee BW, et al. Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia. J Clin Immunol. 2010;30:121-131.
12. Lee PP, Chan KW, Chen TX, Jiang LP, Wang XC, Zeng HS, et al. Molecular diagnosis of severe combined immunodeficiency--identification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and Southeast Asian children. J Clin Immunol. 2011;31:281-296.
13. World Health Organization. Global tuberculosis report 2012 [Internet]. 2012 [cited 2013 Jul 27]. Available from: http://www.who.int/tb/publications/global_report/en/.
14. Hesseling AC, Marais BJ, Gie RP, Schaaf HS, Fine PE, Godfrey-Faussett P, et al. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine. 2007;25:14-18.
15. Norouzi S, Aghamohammadi A, Mamishi S, Rosenzweig SD, Rezaei N. Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases. J Infect. 2012;64:543-554.
16. van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PLoS One. 2009;4:e5234.
17. Lee WI, Huang JL, Lin TY, Hsueh C, Wong AM, Hsieh MY, et al. Chinese patients with defective IL-12/23-interferon-gamma circuit in Taiwan: partial dominant interferon-gamma receptor 1 mutation presenting as cutaneous granuloma and IL-12 receptor beta1 mutation as pneumatocele. J Clin Immunol. 2009;29:238-245.
18. Kusuhara K, Ohga S, Hoshina T, Saito M, Sasaki Y, Ishimura M, et al. Disseminated Bacillus Calmette-Guérin lymphadenitis in a patient with gp91phox- chronic granulomatous disease 25 years after vaccination. Eur J Pediatr. 2009;168:745-747.
19. Barese C, Copelli S, Zandomeni R, Oleastro M, Zelazko M, Rivas EM. X-linked chronic granulomatous disease: first report of mutations in patients of Argentina. J Pediatr Hematol Oncol. 2004;26:656-660.
20. Movahedi M, Aghamohammadi A, Farhoudi A, Moin M, Pourpak Z, Gharagozlou M, et al. Respiratory manifestations of chronic granulomatous disease; a clinical survey of patients from Iranian primary immunodeficiency registry. Iran J Allergy Asthma Immunol. 2003;2:45-51.
21. Naidoo R, Jordaan N, Chan KW, Le Roux DM, Pienaar S, Nuttall J, et al. A novel CYBB mutation with the first genetically confirmed case of chronic granulomatous disease in South Africa. S Afr Med J. 2011;101:768-769.
22. Bustamante J, Aksu G, Vogt G, de Beaucoudrey L, Genel F, Chapgier A, et al. BCG-osis and tuberculosis in a child with chronic granulomatous disease. J Allergy Clin Immunol. 2007;120:32-38.
23. Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med. 2012;367:1035-44.
24. Suputtamongkol Y, Hall AJ, Dance DA, Chaowagul W, Rajchanuvong A, Smith MD, et al. The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand. Int J Epidemiol. 1994;23:1082-1090.
25. Hassan MR, Pani SP, Peng NP, Voralu K, Vijayalakshmi N, Mehanderkar R, et al. Incidence, risk factors and clinical epidemiology of melioidosis: a complex socio-ecological emerging infectious disease in the Alor Setar region of Kedah, Malaysia. BMC Infect Dis. 2010;10:302.
26. Heng BH, Goh KT, Yap EH, Loh H, Yeo M. Epidemiological surveillance of melioidosis in Singapore. Ann Acad Med Singapore. 1998;27:478-484.
27. Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis. 2010;4:e900.
28. Lumbiganon P, Viengnondha S. Clinical manifestations of melioidosis in children. Pediatr Infect Dis J. 1995;14:136-140.
29. Silpapojakul K. Melioidosis in southern Thai chidren. Songkla Med J. 2004;22:363-369.
30. Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, Wongsuvan G, Chaisuksant S, Chetchotisakd P, et al. Increasing incidence of human melioidosis in Northeast Thailand. Am J Trop Med Hyg. 2010;82:1113-1117.
31. Stoesser N, Pocock J, Moore CE, Soeng S, Chhat HP, Sar P, et al. Pediatric suppurative parotitis in Cambodia between 2007 and 2011. Pediatr Infect Dis J. 2012;31:865-868.
32. Winkelstein JA, Marino MC, Johnston RB, Jr., Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155-169.
33. Tarlow MJ, Lloyd J. Melioidosis and chronic granulomatous disease. Proc R Soc Med. 1971;64:19-20.
34. Dorman SE, Gill VJ, Gallin JI, Holland SM. Burkholderia pseudomallei infection in a Puerto Rican patient with chronic granulomatous disease: case report and review of occurrences in the Americas. Clin Infect Dis. 1998;26:889-894.
35. Renella R, Perez JM, Chollet-Martin S, Sarnacki S, Fischer A, Blanche S, et al. Burkholderia pseudomallei infection in chronic granulomatous disease. Eur J Pediatr. 2006;165:175-177.
36. Wuthiekanun V, Cheng AC, Chierakul W, Amornchai P, Limmathurotsakul D, Chaowagul W, et al. Trimethoprim/ sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J Antimicrob Chemother. 2005;55:1029-1031.
37. Paveenkittiporn W, Apisarnthanarak A, Dejsirilert S, Trakulsomboon S, Thongmali O, Sawanpanyalert P, et al. Five-year surveillance for Burkholderia pseudomallei in Thailand from 2000 to 2004: prevalence and antimicrobial susceptibility. J Med Assoc Thai. 2009;92 Suppl 4:S46-S52.
38. Yang CH, Li YH. Chromobacterium violaceum infection: a clinical review of an important but neglected infection. J Chin Med Assoc. 2011;74:435-441.
39. Macher AM, Casale TB, Fauci AS. Chronic granulomatous disease of childhood and Chromobacterium violaceum infections in the southeastern United States. Ann Intern Med. 1982;97:51-55.
40. Sirinavin S, Techasaensiri C, Benjaponpitak S, Pornkul R, Vorachit M. Invasive Chromobacterium violaceum infection in children: case report and review. Pediatr Infect Dis J. 2005;24:559-561.
41. Benjasupattananan P, Simasathein T, Vichyanond P, Leungwedchakarn V, Visitsunthorn N, Pacharn P, et al. Clinical characteristics and outcomes of primary immunodeficiencies in Thai children: an 18-year experience from a tertiary care center. J Clin Immunol. 2009;29:357-364.
42. Voraphani N, Chatchatee P, Ngamphaiboon J, Tongkobpetch S, Suphapeetiporn K, Shotelersuk V. Clinical and molecular characteristics of Thai families with autosomal recessive chronic granulomatous disease. Asian Biomed. 2009;3:603-609.
43. Rashid ZZ, Ali UK, Sulong A, Rahman RA. Chromobacterium Violaceum Infections: A Series Of Case Reports In A Malaysian Tertiary Hospital. The Internet Journal of Infectious Diseases [Internet]. 2013 Sep [cited 2013 Jul 27];11:[about 1 p.]. Available from: http://archive.ispub.com/journal/the-internet-journal-of-infectious-diseases/volume-11-number-1/chromobacterium-violaceum-infections-a-series-of-case-reports-in-a-malaysian-tertiary-hospital.html#sthash.zmsmMgCM.dpbs
44. Saboo AR, Vijaykumar R, Save SU, Bavdekar SB. A rare nonfatal presentation of disseminated Chromobacterium violaceum sepsis. J Microbiol Immunol Infect. 2013.
45. Wardrop RM, Collier A, Leinenweber S, Kocis K, Weston BW, Holland SM. Fulminant sepsis associated with Chromobacterium violaceum in a patient with previously undiagnosed chronic granulomatous disease (CGD) [abstract]. American Academy of Pediatrics National Conference & Exhibition, Oct 9 2005, Washington DC, USA.
46. Teoh AY, Hui M, Ngo KY, Wong J, Lee KF, Lai PB. Fatal septicaemia from Chromobacterium violaceum: case reports and review of the literature. Hong Kong Med J. 2006;12:228-231.
47. Ma SK, Chuang SK, Cheung TL, Kam KM, Tsang HF. A fatal case of Chromobacterium violaceum septicemia in Hong Kong. Southeast Asian J Trop Med Public Health. 2006;37:1179-1182.
48. Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in southeast Asia. Lancet. 1994;344:110-113.
49. Ustianowski AP, Sieu TP, Day JN. Penicillium marneffei infection in HIV. Curr Opin Infect Dis. 2008;21:31-36.
50. Vanittanakom N, Cooper CR, Jr., Fisher MC, Sirisanthana T. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev. 2006;19:95-110.
51. Lee PP, Chan KW, Lee TL, Ho MH, Chen XY, Li CH, et al. Penicilliosis in children without HIV infection--are they immunodeficient? Clin Infect Dis. 2012;54:e8-e19.
52. Tang BS, Chan JF, Chen M, Tsang OT, Mok MY, Lai RW, et al. Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon. Clin Vaccine Immunol. 2010;17:1132-1138.
53. van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, Gilissen C, et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med. 2011;365:54-61.
54. Lee PP, Mao HW, Yang WL, Chan KW, Ho HK, Lee TL, et al. Penicillium marneffei infection and impaired interferon-gamma immunity in humans with autosomal dominant gain-of- phosphorylation STAT1mutations. J Allergy Clin Immunol 2013, in press.
55. Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208:1635-1648.
56. Sampaio EP, Hsu AP, Pechacek J, Bax HI, Dias DL, Paulson ML, et al. Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis. J Allergy Clin Immunol. 2013;131:1624-1634.